Tissue Therapies
HOME TECHNOLOGY INVESTORS ALLIANCES COMPANY
CONTACT


Tissue Therapies Limited provides wound healing, tissue repair and cell culture technology through a novel growth factor platform technology, VitroGro®  


VitroGro® is an animal product free, mulitimeric delivery system for growth factors, enhancing cell replication, protein synthesis and migration.
 
29 Apr 2009
Results of 2nd Patient in Canadian Clinical Trial

13 Mar 2009
Appointment of Mel Bridges as Company Director ]

04 Mar 2009
Rights Issue Exceeds Expectation [PDF]

 
 
 

VitroGro® is available as a coating kit for in vitro mammalian cell culture research purposes and evaluation by interested scientists and potential collaborators and commercials partners or customers following signing of a Materials Transfer Agreement.

The management and technical team of Tissue Therapies are highly qualified and experienced.

Tissue Therapies current share price is available on the ASX.
     
 

02 Feb 2009
Results of 1st Patient in Canadian Trial

30 Jan 2009
2nd South African Patent Granted [PDF]]

28 Jan 2009
Tissue Therapies Prospectus [PDF]

19 Jan 2009
Results of VitroGro Venous Ulcer Human Trial [PDF]

  
 

Tissue Therapies forms alliances with strategic partners worldwide

  
© 2007 TISSUE THERAPIES LTD